Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

immunoconjugate therapy

(IH-myoo-noh-KON-jih-gut THAYR-uh-pee)

A type of treatment that uses an immune substance, such as a monoclonal antibody, that is chemically linked to a cell-killing substance such as a toxin, radioisotope, or drug. The immune substance targets certain types of cells and the linked substance kills the targeted cells without harming other cells. Immunoconjugates are used in the treatment of cancer. Examples include antibody-drug conjugates, immunotoxins, and some targeted therapy drugs.

immunoconjugate therapy

Search NCI's Dictionary of Cancer Terms